Latest Breaking News On - Deciphera pharmaceuticals - Page 3 : comparemela.com

Jefferies Financial Group restated their hold rating on shares of Deciphera Pharmaceuticals (NASDAQ:DCPH – Free Report) in a report released on Monday, Benzinga reports. Jefferies Financial Group currently has a $25.60 price target on the stock, down from their prior price target of $26.00. DCPH has been the topic of several other research reports. Jonestrading […]

United statesStifel nicolausDeciphera pharmaceuticals incJefferies financial groupDeciphera pharmaceuticalsInstitutional trading of deciphera pharmaceuticalsDeciphera pharmaceuticals price performanceNews ratings for deciphera pharmaceuticals dailyExchange traded conceptsChina universal asset management coJpmorgan chase coQuest partnersAnalyst recommendations for deciphera pharmaceuticalsFree reportFinancial groupGet free report